The costs of conventional cholecystectomy, laparoscopic cholecystectomy and biliary lithotripsy - nonsystematic review

Conseil d'Evaluation des Technologies de la Sante du Quebec
Record ID 31996008357
English, French
Authors' objectives:

To compare the direct costs to the Quebec health care system of three different methods of treating gallstone disease.

Authors' results and conclusions: The average costs (and lower and upper bounds) of the three procedures are as follows:1) Conventional Cholecystectomy (CC) -$3,195 ($2,133-$6,331), 2) Laparoscopic Cholecystectomy (LC) - $2,889 ($1,704-$5,830), 3) Extracorporeal Lithotripsy (ESWL) - $3,936 ($2,367-$6,243). Thus, in terms of direct costs to the health care system, LC had a small but definite advantage over the two other interventions. If all professional fees are excluded, the costs of the two surgical procedures are $2,058 ($651-$4,419) for CC and $1,902 ($927-$5,511) for LC. Thus, in terms of a hospital's budget, the cost of LC is only very slightly lower. However, the principal cause of the lower cost of LC is the shorter hospital stay. A hospital which uses the beds liberated by conversion from CC to LC for other cases of equal intensity, will incur an increased load on its budget of the order of $464 per case.
Details
Project Status: Completed
Year Published: 1993
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Cholecystectomy
  • Cholecystectomy, Laparoscopic
  • Cholelithiasis
  • Costs and Cost Analysis
  • Lithotripsy
Contact
Organisation Name: Conseil d'Evaluation des Technologies de la Santé du Québec
Contact Address: Conseil d'Evaluation des Technologies de la Santé du Québec, 2021, avenue Union, #1040, Montréal, Québec H3A S29, Canada. Tel: 514-873-2563; FAX: 514-873-1369
Contact Name: aetmis@aetmis.gouv.qc.ca
Contact Email: aetmis@aetmis.gouv.qc.ca
Copyright: Conseil d'Evaluation des Technologies de la Sante du Quebec (CETS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.